These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 23474241

  • 1. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ.
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [Abstract] [Full Text] [Related]

  • 2. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 3. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y, Chakravarty S, Li M, Wai TT, Hoffman SL, Sim BK.
    J Infect Dis; 2017 Jan 15; 215(2):259-268. PubMed ID: 27803169
    [Abstract] [Full Text] [Related]

  • 4. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
    Xu DQ, Cisar JO, Ambulos N, Burr DH, Kopecko DJ.
    Infect Immun; 2002 Aug 15; 70(8):4414-23. PubMed ID: 12117952
    [Abstract] [Full Text] [Related]

  • 5. Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection.
    Xu DQ, Cisar JO, Osorio M, Wai TT, Kopecko DJ.
    Vaccine; 2007 Aug 14; 25(33):6167-75. PubMed ID: 17629369
    [Abstract] [Full Text] [Related]

  • 6. Stable expression of Shigella dysenteriae serotype 1 O-antigen genes integrated into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN, Osorio M, Filipova S, Marsh C, Stibitz S, Kopecko DJ.
    Pathog Dis; 2016 Nov 14; 74(8):. PubMed ID: 27655911
    [Abstract] [Full Text] [Related]

  • 7. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
    Black RE, Levine MM, Clements ML, Losonsky G, Herrington D, Berman S, Formal SB.
    J Infect Dis; 1987 Jun 14; 155(6):1260-5. PubMed ID: 2437220
    [Abstract] [Full Text] [Related]

  • 8. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
    Viret JF, Cryz SJ, Lang AB, Favre D.
    Mol Microbiol; 1993 Jan 14; 7(2):239-52. PubMed ID: 7680409
    [Abstract] [Full Text] [Related]

  • 9. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.
    Clin Vaccine Immunol; 2007 Oct 14; 14(10):1285-95. PubMed ID: 17687110
    [Abstract] [Full Text] [Related]

  • 10. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
    Hotz C, Fensterle J, Goebel W, Meyer SR, Kirchgraber G, Heisig M, Fürer A, Dietrich G, Rapp UR, Gentschev I.
    Int J Med Microbiol; 2009 Feb 14; 299(2):109-19. PubMed ID: 18706861
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.
    Formal SB, Baron LS, Kopecko DJ, Washington O, Powell C, Life CA.
    Infect Immun; 1981 Dec 14; 34(3):746-50. PubMed ID: 6174449
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X, Xu Y, Wan H, Su G, Huang C.
    Chin J Biotechnol; 1996 Dec 14; 12(2):89-97. PubMed ID: 8988355
    [Abstract] [Full Text] [Related]

  • 19. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG, Mansouri E, Kronawitter M, Diescher S, Soerensen M, Hurwitz R, Bumann D, Aebischer T, Von Specht BU, Meyer TF.
    Vaccine; 2004 Jun 02; 22(17-18):2273-7. PubMed ID: 15149786
    [Abstract] [Full Text] [Related]

  • 20. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
    Tramont EC, Chung R, Berman S, Keren D, Kapfer C, Formal SB.
    J Infect Dis; 1984 Feb 02; 149(2):133-6. PubMed ID: 6366077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.